Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
Clinical trial NCT03441360 · COMPLETED
Trial details
- NCT number
- NCT03441360
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2021-01-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.